ADENOVIRUS TYPE 7 (adenovirus vaccine live type-7)
ADENOVIRUS TYPE 7 VACCINE · ADENOVIRUS TYPES 4, 7 VACCINATION
TEVA WOMEN'S HE
Drug class
Adenovirus Type 7 Vaccine
Adenovirus Type 7 Vaccine is an active immunizing agent classified formally by the FDA under the established pharmacologic class live human adenovirus type 7 vaccine. Read more about Adenovirus Type 7 Vaccine
2 drugs in this class 1 manufacturers
Drugs in Adenovirus Type 7 Vaccine
ADENOVIRUS TYPE 4 AND TYPE 7 (adenovirus live type-4 and adenovirus live type-7 vaccine)
ADENOVIRUS TYPE 4 VACCINE · ADENOVIRUS TYPES 4, 7 VACCINATION
TEVA WOMEN'S HE
Filter & compare in the drug finder →
Opens the drug finder with Adenovirus Type 7 Vaccine preselected. Add indication or manufacturer filters there.
Adenovirus Type 7 Vaccine is an active immunizing agent classified formally by the FDA under the established pharmacologic class live human adenovirus type 7 vaccine.
In clinical practice, it represents a specific live-virus vaccine component rather than a broad, multi-agent therapeutic class.
It works by releasing live, attenuated virus in the intestine via an enteric-coated formulation to establish an asymptomatic local infection that elicits neutralizing antibodies against human adenovirus serotype 7 without producing respiratory symptoms.
It is primarily co-administered with adenovirus type 4 vaccine to prevent acute respiratory disease and severe febrile respiratory illness in high-risk populations, particularly military recruits.
-
fda.gov
Adenovirus Type 7 Vaccine is an active immunizing agent classified formally by the FDA under the established pharmacologic class live human adenovirus type 7 vaccine
-
nih.gov
In clinical practice, it represents a specific live-virus vaccine component rather than a broad, multi-agent therapeutic class
-
ashp.org
In clinical practice, it represents a specific live-virus vaccine component rather than a broad, multi-agent therapeutic class It works by releasing live, attenuated virus in the intestine via an enteric-coated formulation to establish an asymptomatic local infection that elicits neutralizing antibodies against human adenovirus serotype 7 without producing respiratory symptoms It is primarily co-administered with adenovirus type 4 vaccine to prevent acute respiratory disease and severe febrile r...
-
drugs.com
It works by releasing live, attenuated virus in the intestine via an enteric-coated formulation to establish an asymptomatic local infection that elicits neutralizing antibodies against human adenovirus serotype 7 without producing respiratory symptoms It is primarily co-administered with adenovirus type 4 vaccine to prevent acute respiratory disease and severe febrile respiratory illness in high-risk populations, particularly military recruits
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.